Ramsay moves to improve Elysium performance as challenges impact H1 profit

Ramsay Health Care has paused all capital expenditure on site expansion at its UK mental health business Elysium to focus on improving performance. The news comes as the Australian healthcare giant said it expects to book a £151m impairment against its UK business when it reports its H1 accounts later this month. Despite an increased…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?